首页> 外文期刊>Journal of biomedicine & biotechnology >Progenitors for the Curneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma
【24h】

Progenitors for the Curneal Endothelium and Trabecular Meshwork: A Potential Source for Personalized Stem Cell Therapy in Corneal Endothelial Diseases and Glaucoma

机译:角膜内皮和小梁网的祖细胞:个性化干细胞治疗角膜内皮病和青光眼的潜在来源。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Several adult stem cell types have been found In different parts of the eye, including the corneal epithelium, conjunctiva, and retina. In addition to these, there have been accumulating evidence that some stem-like cells reside in the transition area between the peripheral corneal endothelium (CE) and the anterior nonfiltering portion of the trabecular meshwork (TM), which is known as the Schwalbe's Ring region. These stem/progenitor cells may supply new cells for the CE and TM. In fact, the CE and TM share certain similarities in terms of their embryonic origin and proliferative capacity in vivo. In this paper, we discuss the putative stem cell source which has the potential for replacement of lost and nonfunctional cells in CE diseases and glaucoma. The future development of personalized stem cell therapies for the CE and TM may reduce the requirement of corneal grafts and surgical treatments in glaucoma.
机译:在眼睛的不同部位发现了几种成人干细胞类型,包括角膜上皮,结膜和视网膜。除此之外,越来越多的证据表明,一些干样细胞存在于周围角膜内皮(CE)和小梁网(TM)的前非滤过部分之间的过渡区域,该区域称为Schwalbe环区。这些干/祖细胞可能会为CE和TM提供新的细胞。实际上,CE和TM在胚胎来源和体内增殖能力方面具有某些相似性。在本文中,我们讨论了推定的干细胞来源,该来源具有替代CE疾病和青光眼中丢失和失去功能的细胞的潜力。 CE和TM个性化干细胞疗法的未来发展可能会减少青光眼中角膜移植物和外科治疗的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号